Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

12

Number of overlapping holdings

19.7%

% of BBP's 65 holdings also in CNCR

16.7%

% of CNCR's 77 holdings also in BBP

Overlap by Weight
Sector Drift (BBP minus CNCR)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in BBP
Weight
in CNCR
Overlap
Y-MABS THERAPEUTICS, INC. 1.5% 1.5% 1.5%
IOVANCE BIOTHERAPEUTICS INC 1.6% 1.5% 1.5%
DAY ONE BIOPHARMACEUTICALS, INC. 1.8% 1.5% 1.5%
IMMUNITYBIO INC 1.4% 2.1% 1.4%
EXELIXIS INC 1.6% 1.4% 1.4%

Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to CNCR
MIRUM PHARMACEUTICALS, INC. 2.4%
ALNYLAM PHARMACEUTICALS INC 2.1%
TRAVERE THERAPEUTICS, INC. 2.0%
LIGAND PHARMACEUTICALS-CL B 1.9%
LEXICON PHARMACEUTICALS, INC. 1.9%
ACADIA PHARMACEUTICALS INC 1.9%
BIOCRYST PHARMACEUTICALS INC 1.8%
IONIS PHARMACEUTICALS, INC. 1.8%
TG THERAPEUTICS INC 1.8%
ADMA BIOLOGICS, INC. 1.8%
BBP Underweight Relative to CNCR
BIOMEA FUSION INC -2.1%
GINKGO BIOWORKS HOLDINGS INC CLASS A -1.8%
ENLIVEN THERAPEUTICS, INC. -1.8%
HUTCHISON CHINA MEDITECH LIMITED SPO -1.7%
REPLIMUNE GROUP, INC. -1.5%
AUTOLUS THERAPEUTICS PLC SPONSORED A -1.5%
ARCELLX, INC. -1.5%
AURA BIOSCIENCES INC -1.5%
TYRA BIOSCIENCE, INC -1.5%
KARYOPHARM THERAPEUTICS INC -1.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY